Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 3 analysts offering 12 month price targets for Vistagen Therapeutics Inc have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 12.00. The median estimate represents a 300.00% increase from the last price of 3.00.
High | 400.0% | 15.00 |
Med | 300.0% | 12.00 |
Low | 300.0% | 12.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 07, 2024.
Average growth rate | +18.83% |
Average growth rate | +29.90% |
More ▼
Revenue history & estimates in USD
Average growth rate | -0.91% |
Average growth rate | -0.74% |
More ▼